Medicare Enrolled

Dr. Natalia Anchipolovsky, DO

Endocrinology · Hackensack, NJ
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
77 PROSPECT AVE, Hackensack, NJ 07601
2018203596
In practice since 2007 (19 years)
NPI: 1982725024 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Anchipolovsky from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Anchipolovsky? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Anchipolovsky

Dr. Natalia Anchipolovsky is an endocrinology specialist in Hackensack, NJ, with 19 years of NPI registration. Based on federal Medicare data, Dr. Anchipolovsky performed 1,989 Medicare services across 1,221 unique beneficiaries.

Between the years covered by Open Payments, Dr. Anchipolovsky received a total of $54,145 from 46 pharmaceutical and/or device companies across 427 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Anchipolovsky is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 27% volume in NJ $54,145 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,989
Medicare services
Top 27% in NJ for endocrinology
1,221
Unique beneficiaries
$98
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~105 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
957 $113 $177
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
349 $80 $123
Continuous glucose monitoring with interpretation
This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results.
231 $30 $50
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
171 $146 $381
Telephone medical discussion, 21-30 minutes
A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone.
90 $95 $121
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
55 $160 $340
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
55 $71 $91
Non-hormonal chemotherapy injection
This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue.
47 $68 $150
Telephone medical discussion, 5-10 minutes
A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters.
19 $48 $60
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
15 $152 $385
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$54,145
Total received (2018-2024)
Avg $7,735/year across 7 years
Top 7% in NJ for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
46
Companies
427
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$48,103 (88.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,042 (11.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,214
2023
$2,188
2022
$6,154
2021
$5,740
2020
$11,015
2019
$11,374
2018
$16,459

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$329
Lilly USA, LLC
$213
Novo Nordisk Inc
$186
Dexcom, Inc.
$78
Medtronic, Inc.
$63
IBSA Pharma Inc.
$43
Corcept Therapeutics
$40
SANOFI-AVENTIS U.S. LLC
$40
Novartis Pharmaceuticals Corporation
$37
AstraZeneca Pharmaceuticals LP
$31
ABBVIE INC.
$31
Chiesi USA, Inc.
$30
Amneal Pharmaceuticals LLC
$30
Radius Health, Inc.
$22
Xeris Pharmaceuticals, Inc.
$15
Boehringer Ingelheim Pharmaceuticals, Inc.
$14
Neurocrine Biosciences, Inc.
$14
Top 3 companies account for 59.9% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$47,818
Amgen Inc.
$1,117
Lilly USA, LLC
$907
Novo Nordisk Inc
$650
SANOFI-AVENTIS U.S. LLC
$467
Corcept Therapeutics
$402
AbbVie Inc.
$342
Abbott Laboratories
$221
Amarin Pharma Inc.
$194
PFIZER INC.
$176
Boehringer Ingelheim Pharmaceuticals, Inc.
$159
Xeris Pharmaceuticals, Inc.
$113
Amneal Pharmaceuticals LLC
$111
Medtronic, Inc.
$108
Bayer HealthCare Pharmaceuticals Inc.
$105
ARBOR PHARMACEUTICALS, INC.
$99
Mannkind Corporation
$88
IBSA Pharma Inc.
$83
CeQur Corporation
$79
Dexcom, Inc.
$78
Merck Sharp & Dohme Corporation
$71
Medtronic MiniMed, Inc.
$62
ABBVIE INC.
$56
RECORDATI_RARE_DISEASES_INC.
$54
Alexion Pharmaceuticals, Inc.
$43
Takeda Pharmaceuticals U.S.A., Inc.
$40
Azurity Pharmaceuticals, Inc.
$40
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$38
Novartis Pharmaceuticals Corporation
$37
VIVUS, Inc.
$34
Zealand Pharma US, Inc.
$34
Radius Health, Inc.
$33
Insulet Corporation
$33
Chiesi USA, Inc.
$30
Amryt Pharma Holdings Ltd
$30
Currax Pharmaceuticals LLC
$29
VistaPharm, Inc.
$27
Senseonics, Incorporated
$21
Arbor Pharmaceuticals, Inc.
$19
Regeneron Healthcare Solutions, Inc.
$16
MannKind Corporation
$15
Janssen Pharmaceuticals, Inc
$14
Ipsen Biopharmaceuticals, Inc
$14
Neurocrine Biosciences, Inc.
$14
EUSA Pharma (US) LLC
$13
AbbVie, Inc.
$12
Top 3 companies account for 92.1% of all-time payments
Associated products mentioned in payments ›
AFREZZA · Adthyza · BAQSIMI · BYDUREON · CONTRAVE · CRENESSITY · CREON · CYCLOSET · CeQur Simplicity · Dexcom G6 Transmitter · EVENITY · EVKEEZA · Edarbi · Eversense · FARXIGA · FreeStyle Libre · GVOKE HYPOPEN · GVOKE PFS · Guardian Connect · HUMULIN · INVOKAMET · ISTURISA · JANUVIA · JARDIANCE · Kerendia · Korlym · LEQVIO · LICART · LINZESS · LOKELMA · MINIMED 770G · MINIMED 780G · MOUNJARO · MYCAPSSA · Minimed 670G System · NovoLog · Omnipod · Ozempic · Prolia · QSYMIA · RECORLEV · RYBELSUS · Repatha · Rybelsus · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · SOMATULINE DEPOT · SOMAVERT · STRENSIQ · SYNTHROID · Saxenda · Strensiq · Sylvant · Synthroid · TEPEZZA · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Thyquidity · Tirosint · Tresiba · Tymlos · UNITHROID · Vascepa · Wegovy · XIGDUO · ZEGALOGUE · ZEPBOUND
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (89%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in endocrinology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 7% for endocrinology in NJ.

Looking for an endocrinology specialist in Hackensack?
Compare endocrinologists in the Hackensack area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists within 10 mi
673
Per 100K population
70.5
County median income
$123,715
Nearest hospital
HACKENSACK UNIVERSITY MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Anchipolovsky is a clinical cardiology specialist, with above-average Medicare volume (top 27% in NJ), with speaking/promotional industry engagement in the top 7% of NJ peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Anchipolovsky experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Anchipolovsky performed 957 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Anchipolovsky receive payments from pharmaceutical companies?
Yes. Dr. Anchipolovsky received a total of $54,145 from 46 companies across 427 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Anchipolovsky's costs compare to other endocrinologists in Hackensack?
Dr. Anchipolovsky's average Medicare payment per service is $98. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Anchipolovsky) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →